Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia

NCT00003729 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

NETWORK

Sponsor class

Stopped low accrual

Conditions

Leukemia

Interventions

DRUG: cytarabine
DRUG: fludarabine phosphate
DRUG: idarubicin

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC